• Home
  • Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.

Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.

Author List
Levin VA, Phuphanich S, Liu HC, Da Silva V, Murovic J, Choucair A, Chamberlain M, Berger M, Seager M, Davis RL
Publication
Cancer treatment reports
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1171618
Publication Year
1986
PubMed ID
3021325
Publication Title
Levin VA, Phuphanich S, Liu HC, Da Silva V, Murovic J, Choucair A, Chamberlain M, Berger M, Seager M, Davis RL. Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas. Cancer Treat Rep. 1986 Nov; 70(11):1271-4.